DEINOVE announced its collaboration with the Max Mousseron Institute of Biomolecules (IBMM) and the Physical Measurement Laboratory (LMP) of the University of Montpellier for the co-development of new analytical approaches based on the use of Ultra High Resolution Mass Spectrometry, over a 30-month period. This project benefits from a €990,000 funding from the European Regional Development Fund (FEDER) and the Occitania Region. The ATB-Discover partnership research project was selected in the framework of the call for proposals “Regional Research and Innovation Platforms” (PRRI), in line with the regional innovation strategy “Innovative and targeted therapies”. ATB-Discover aims to complete and strengthen DEINOVE’s in-house analytical capabilities. This project is in total synergy with DEINOVE’s industrial strategy for the development of new antimicrobials, which was recently supported by two other independent expert committees. ATB-Discover also contributes to the territorial policy by federating a scientific, institutional and economic community committed to the societal challenges of MUSE “Montpellier University of Excellence: Nourish/Care/Protect”3. This innovative collaborative research project relies on a vast range of techniques and expertise in analytical chemistry, and more particularly in mass spectrometry, available at the Max Mousseron Institute of Biomolecules4 and the Physical Measurement Laboratory5. ATB-Discover will accelerate the identification of active antimicrobial molecules in bacterial extracts at DEINOVE: Better detection of molecules of interest based on increased sensitivity during analysis; Determination of the molecular formula of each molecule of interest enabled by the extreme precision of Ultra High Resolution; Rapid determination of structures of unknown molecules using a dedicated software suite.